University of Washington logo

University of Washington

The University of Washington is a public research university in Seattle operating in higher education, research, and computer science; it...

Facts

HQ
University of Washington
Sectors
Higher Education, Research, Healthcare, Arts
Founded
1861
Registered name
University of Washington Seattle business license
Stage
Public

UW Oceanographers Launch Banyu Carbon Startup to Remove CO2 from Seawater, Raising $8.5M and Securing $500K CO2 Removal Deal

University of Washington oceanographers Julian Sachs and Alex Gagnon co-founded Banyu Carbon, a startup developing technology to extract carbon dioxide from seawater to combat climate change. The Seattle-based company has raised $8.5 million, secured a $500,000 contract to remove 350 tons of CO2 by 2026, and is supported by notable programs and investors.

Techstars CEO Maëlle Gavet Rebukes Former Seattle MD Chris DeVore Over Criticism Amid Seattle Program Closure

Techstars CEO Maëlle Gavet responded critically to former managing director Chris DeVore's blog post blaming strategic decisions for the closure of Techstars Seattle, emphasizing ongoing support for local entrepreneurs despite the program's shutdown. DeVore had publicly criticized Techstars' reliance on corporate sponsors and changes in incentives prior to the announcement.

Ascend.vc’s Kirby Winfield Highlights AI Investing Strategy and Pacific Northwest Startup Growth on Shift AI Podcast

Kirby Winfield, founding general partner at Ascend.vc, discusses his shift from entrepreneur to Seattle-based AI-focused venture capitalist and shares insights on AI investing, emphasizing use cases solving real problems efficiently. Ascend.vc positions itself as a prolific pre-seed investor in the Pacific Northwest, focusing on applied AI as a next-generation vertical software.

AstraZeneca to Acquire UW Spinout Icosavax for Up to $1.1 Billion to Boost Respiratory Vaccine Development

AstraZeneca announced it will acquire Seattle-based biotech spinout Icosavax, founded at the University of Washington, for up to $1.1 billion to accelerate development of vaccines targeting respiratory viruses. Icosavax's shares surged over 40% after the deal, which values the company at a 43% premium and aims to advance its lead RSV and hMPV vaccine candidate.

Oscilla Power Deploys Triton-C Wave Energy Device in Hawaii; Plans 1MW Triton Test in Maine for Utility-Scale Ocean Power

Oscilla Power is testing its Triton-C wave energy device in Hawaii and plans a larger Triton device test in Maine, aiming to generate utility-scale ocean wave power along the U.S. West Coast. The startup seeks to harness multi-directional wave movements for clean electricity, with the Triton-C demo soon connecting to the grid to power about 25 homes.

Seattle Startup Sironix Renewables Raises $1.47M to Scale Eco-Friendly Soy-Based Surfactants

Seattle clean-tech startup Sironix Renewables raised $1.47 million to scale production of its eco-friendly soy-based surfactants for shampoos, detergents, and other personal care products. Their product, Eosix, offers a sustainable alternative to fossil fuel-derived chemicals with 45% lower greenhouse gas emissions and avoids carcinogenic contaminants like 1,4-dioxane.

Viome raises $86.5M Series C and partners with CVS to sell $179 at-home Full Body Intelligence gut test in 200 stores

Seattle-area health tech startup Viome Life Sciences raised an $86.5 million Series C and struck a deal to sell its $179 at-home Full Body Intelligence gut microbiome test in 200 CVS stores and online. Founded by Naveen Jain, Viome analyzes stool, saliva and blood samples and counts investors including Marc Benioff and Khosla Ventures, though some scientists question clinical utility of microbiome kits.

Phase Genomics Secures $2.5M to Develop AI Platform for Detecting Cancer Chromosomal Aberrations

Seattle startup Phase Genomics received $2.5 million in funding, including $2 million from the U.S. National Cancer Institute and $500,000 from Washington state's Andy Hill CARE Fund, to advance its AI-driven platform that detects chromosomal aberrations in cancer. The funding supports projects analyzing tumor samples to develop predictive scores for cancers like acute myeloid leukemia and colorectal cancer.

  • Oren Etzioni
    Oren Etzioni Executive, Former CEO, Founder and Emeritus Professor, Former Professor, Former Leader of TrueMedia
  • Avi Geiger Lecturer, Affiliate Assistant Professor, Electrical and Computer Engineering
  • Babak Parviz
    Babak Parviz Professor

Online